Skip Navigation

skip navigationNIDDK Home
NIDDK Reference Collection
Diet   Exercise   Health  
Home Page
-  

FAQ

Detailed Search

- -
NIDDK INFORMATION SERVICES
- -

Diabetes

Digestive Diseases

Endocrine and Metabolic Diseases

Hematologic Diseases

Kidney and Urologic Diseases

Weight-control Information Network

-
NIDDK EDUCATION
PROGRAMS

- -

National Diabetes Education Program

National Kidney Disease Education Program

-
- - -
NIDDK Home
-
Contact Us
-
New Search
-
Topic: hematologic diseases (he)
Title: Aspirin and Clopidogrel Resistance.
Author: Fitzgerald, D.J.; Maree, A.
Source: IN: Hematology 2007. Washington, DC: American Society of Hematology. 2007. pp. 114-120.
Availability: Available from American Society of Hematology. 1900 M Street NW, Suite 200, Washington, DC 20036. Email: ASH@hematology.org. Website: www.asheducationbook.org. Price: Available free on website.
Abstract: This chapter, from the annual Hematology 2007, reviews the use of aspirin and clopidogrel in patients with cardiovascular disease, focusing on patients who experience aspirin and clopidogrel “resistance.” The authors caution that this term infers a lack of therapeutic response and a single underlying mechanism, which is misleading. The incidence of “resistance” detected in clinical studies varies with the definition applied and assay used to measure response. Rather than true resistance, however, there is a variable patient response that reflects the unique pharmacology and pharmacokinetics of each drug, the clinical significance of which remains to be established. The authors discuss true “aspirin resistance” in which, despite 95 percent inhibition of serum thromboxane B2 by aspirin, residual platelet aggregation is detected in some cases. They consider whether heritable factors directly and indirectly related to platelet cyclooxygenase may influence aspirin response. The authors conclude that, in contrast to aspirin, the response to clopidogrel is highly variable and reflects the bioavailability of the active metabolite and not “resistance” of the receptor to inhibition. 2 tables. 46 references.

Format: Monograph/Book
Language: English.
Major Keywords: Hematologic Diseases. Aspirin. Cardiovascular Diseases. Thrombosis. Drug Effects. Patient Care Management.
Minor Keywords: Clinical Trials. Administration and Dosage. Complications. Platelets.
Publication Number: HEBK10212
Printer-Friendly Version | Return to Search Results
<-- previous record | next record -->

View NIDDK Publications | NIDDK Health Information | Contact Us

The NIDDK Reference Collection is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
NIDDK Clearinghouses Publications Catalog
5 Information Way
Bethesda, MD 20892–3568
Phone: 1–800–860–8747
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: catalog@niddk.nih.gov

Privacy | Disclaimers | Accessibility | Public Use of Materials
H H S logo - link to U. S. Department of Health and Human Services NIH logo - link to the National Institute of Health NIDDK logo - link to the National Institute of Diabetes and Digestive and Kidney Diseases